RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (IST:RTALB)

Turkey · Delayed Price · Currency is TRY

2.600

+0.230 (9.70%)

At close: Oct 9, 2026

Market Cap	1.30B -41.4%
Revenue (ttm)	272.72M +10.4%
Net Income	-107.75M
EPS	-0.22
Shares Out	500.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,753,315
Open	2.380
Previous Close	2.370
Day's Range	2.300 - 2.600
52-Week Range	1.840 - 5.080
Beta	0.48
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 28, 2026

About IST:RTALB

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers real-time PCR kits, nucleic acid extraction kits, microbiology media, microbiology stains, and rapid tests; standards and reference materials, and membrane filters; chemicals and reactives, membrane filters, microbiology gas generators, and other consumables; and instruments and consumables. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Tic... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1996

Employees 73

Stock Exchange Istanbul Stock Exchange

Ticker Symbol RTALB

Full Company Profile

Financial Performance

In 2025, IST:RTALB's revenue was 239.56 million, an increase of 15.41% compared to the previous year's 207.58 million. Earnings were 881.18 million, an increase of 1188.81%.

Financial Statements